Our fair value estimate for Iress is AUD 9.00 per share. Our discounted cash flow valuation assumes a weighted average cost of capital of 9%.

Chinese-made medical devices are found in almost every corner of the medical ecosystem, from hospitals to clinics, and the ...

Businesses today are changing by global market conditions and due to technological growth. Traditional MBA, specialized MBAs ...

Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic ...

Strategy to increase capital and enhance financial solvency New services to provide comprehensive solutions for various ...

But for three bloody years, Russia’s invasion of Ukraine has delivered exactly that. Hundreds of thousands of Russians and ...

The Philippines has successfully exited the grey list of the Financial Action Task Force (FATF) following reforms implemented by the Securities and Exchange Commission (SEC) to enhance financial ...

In its memorandum, ICMAI highlighted the extensive training of Cost and Management Accountants (CMAs), which includes expertise in taxation, finance, auditing, corporate laws, and strategic risk ...

At various times, President Bola Tinubu has often declared the commitment of his administration to winning the war against insecurity ...

As real estate developer Article Student Living looked to the future, the team knew they needed a network of prop tech ...

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and SingHealth, Singapore's largest public healthcare cluster, today announced a ...